93 related articles for article (PubMed ID: 7085277)
1. [Budd-Chiari syndrome in DTIC therapy].
Swensson-Beck H; Trettel WH
Hautarzt; 1982 Jan; 33(1):30-1. PubMed ID: 7085277
[TBL] [Abstract][Full Text] [Related]
2. [Dacarbazine (DTIC) therapy and the Budd-Chiari syndrome].
Balda BR; Bassermann R
MMW Munch Med Wochenschr; 1980 May; 122(21):792-4. PubMed ID: 6771598
[TBL] [Abstract][Full Text] [Related]
3. [Budd-Chiari syndrome during treatment with dacarbazine (DTIC) (author's transl)].
Runne U; Doepfmer K; Antz H; Groth W; FEAUX DE Lacroix W
Dtsch Med Wochenschr; 1980 Feb; 105(7):230-3. PubMed ID: 6986251
[TBL] [Abstract][Full Text] [Related]
4. [Budd-Chiari syndrome following dacarbazine therapy of malignant melanoma--an avoidable complication?].
Leyh F; Winzer M; Weber M; Hypa F
Z Hautkr; 1985 Jun; 60(12):961-72. PubMed ID: 4024678
[TBL] [Abstract][Full Text] [Related]
5. [Dacarbazine in malignant melanoma. Rare, severe side-effect: Budd-Chiari-syndrome (author's transl)].
Doering C; Pickartz H; Orfanos CE; Altenähr E
Z Hautkr; 1982 Jul; 57(13):971-80. PubMed ID: 7113323
[TBL] [Abstract][Full Text] [Related]
6. Fatal hepatic vascular toxicity of DTIC. Is it really a rare event?
Ceci G; Bella M; Melissari M; Gabrielli M; Bocchi P; Cocconi G
Cancer; 1988 May; 61(10):1988-91. PubMed ID: 3359400
[TBL] [Abstract][Full Text] [Related]
7. Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanoma.
Frosch PJ; Czarnetzki BM; Macher E; Grundmann E; Gottschalk I
J Cancer Res Clin Oncol; 1979; 95(3):281-6. PubMed ID: 528568
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiological aspects of dacarbazine-induced human liver damage.
Paschke R; Heine M
Hepatogastroenterology; 1985 Dec; 32(6):273-5. PubMed ID: 4093126
[TBL] [Abstract][Full Text] [Related]
9. [DTIC: effect on fibrinolysis and thrombocyte function].
Biltz H; Budde U; Fiedler U; Harbrecht U; Kreysel HW
Onkologie; 1986 Oct; 9(5):270-3. PubMed ID: 3543778
[TBL] [Abstract][Full Text] [Related]
10. Hepatic vascular toxicity of dacarbazine (DTIC): not a rare complication.
Marsh JC
Hepatology; 1989 May; 9(5):790-2. PubMed ID: 2707742
[No Abstract] [Full Text] [Related]
11. Veno-occlusive liver disease after dacarbazine therapy (DTIC) for melanoma.
Erichsen C; Jönsson PE
J Surg Oncol; 1984 Dec; 27(4):268-70. PubMed ID: 6503301
[TBL] [Abstract][Full Text] [Related]
12. Hepatic veno-occlusive disease due to DTIC.
Asbury RF; Rosenthal SN; Descalzi ME; Ratcliffe RL; Arseneau JC
Cancer; 1980 May; 45(10):2670-4. PubMed ID: 7379000
[TBL] [Abstract][Full Text] [Related]
13. Budd-Chiari syndrome: a common complication of Behçet's disease.
Bayraktar Y; Balkanci F; Bayraktar M; Calguneri M
Am J Gastroenterol; 1997 May; 92(5):858-62. PubMed ID: 9149201
[TBL] [Abstract][Full Text] [Related]
14. Budd-Chiari syndrome in women taking oral contraceptives.
Tsung SH; Han D; Loh WP; Lin JI
Ann Clin Lab Sci; 1980; 10(6):518-22. PubMed ID: 7447394
[TBL] [Abstract][Full Text] [Related]
15. [Veno-occlusive syndrome with acute liver dystrophy following decarbazine therapy of malignant melanoma (author's transl)].
Voigt H; Caselitz J; Jänner M
Klin Wochenschr; 1981 Mar; 59(5):229-36. PubMed ID: 7218735
[TBL] [Abstract][Full Text] [Related]
16. [Hepatic vein thrombosis (Budd-Chiari syndrome) appearing during therapy with Lyndiol].
Sterup K
Ugeskr Laeger; 1968 Aug; 130(35):1437-9. PubMed ID: 5701095
[No Abstract] [Full Text] [Related]
17. Acute hepatic vein thrombosis occurring during therapy for Hodgkin's disease: a case report.
Houghton AN; Shafi N; Rickles FR
Cancer; 1979 Dec; 44(6):2324-9. PubMed ID: 509400
[TBL] [Abstract][Full Text] [Related]
18. The transjugular intrahepatic portosystemic stent-shunt (TIPS) as rescue therapy for complete Budd-Chiari syndrome and portal vein thrombosis.
Opitz T; Buchwald AB; Lorf T; Awuah D; Ramadori G; Nolte W
Z Gastroenterol; 2003 May; 41(5):413-8. PubMed ID: 12772054
[TBL] [Abstract][Full Text] [Related]
19. Acute partial Budd-Chiari syndrome and portal vein thrombosis in cytomegalovirus primary infection: a case report.
Spahr L; Cerny A; Morard I; Rubbia-Brandt L; Schrenzel J
BMC Gastroenterol; 2006 Mar; 6():10. PubMed ID: 16529659
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Budd-Chiari syndrome by transjugular intrahepatic portosystemic shunt.
Panagiotou I; Kelekis DA; Karatza C; Nikolaou V; Mouyia V; Brountzos EN
Hepatogastroenterology; 2007 Sep; 54(78):1813-6. PubMed ID: 18019724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
